Louisiana Woman Files Lipitor Diabetes Lawsuit

May 21, 2014 — The Pennsylvania Record reports that Pfizer is facing a lawsuits from a woman who developed type-2 diabetes after taking Lipitor (atorvastatin) to control high cholesterol levels.

The woman, Mary Hoover, is resident of Louisiana filed the lawsuit in federal court in Pennsylvania. She says she took Lipitor from 2006 through 2012 to lower her levels of low-density lipoprotein (LDL) cholesterol and to reduce her risk of cardiovascular disease. In the spring of 2013, she was diagnosed with type-2 diabetes.

As a result of her diagnosis of diabetes, Hoover must undergo routine testing of her blood-sugar levels, adhere to a strict diet, and take medication to control symptoms. Even with treatment, she has an increased risk of heart disease, blindness, neuropathy, and kidney disease.

As of April 2014, there were 464 lawsuits involving Lipitor and diabetes pending in a federal Multi-District Litigation (MDL No. 2502). The litigation has grown rapidly and is now overseen by Judge Richard M. Gergel in the U.S. District Court for South Carolina.

Plaintiffs allege that Pfizer did not adequately warn about the risk of type-2 diabetes from Lipitor. In February 2012, the U.S. Food and Drug Administration (FDA) approved safety warnings about diabetes on the label for Lipitor and other cholesterol-lowering statins.

Need a Texas Lipitor Lawyer?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Lipitor lawyers for a free lawsuit review.